Anti-HLAG/ HLA-G/ MHC-G monoclonal antibody
Anti-HLAG/ HLA-G/ MHC-G antibody for FACS & in-vivo assay
Go to HLA-G/HLA-G products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0590-Ab-1/ GM-Tg-hg-MP0590-Ab-2 | Anti-Human HLA-G monoclonal antibody | Human |
GM-Tg-rg-MP0590-Ab-1/ GM-Tg-rg-MP0590-Ab-2 | Anti-Rat HLA-G monoclonal antibody | Rat |
GM-Tg-mg-MP0590-Ab-1/ GM-Tg-mg-MP0590-Ab-2 | Anti-Mouse HLA-G monoclonal antibody | Mouse |
GM-Tg-cynog-MP0590-Ab-1/ GM-Tg-cynog-MP0590-Ab-2 | Anti-Cynomolgus/ Rhesus macaque HLA-G monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0590-Ab-1/ GM-Tg-felg-MP0590-Ab-2 | Anti-Feline HLA-G monoclonal antibody | Feline |
GM-Tg-cang-MP0590-Ab-1/ GM-Tg-cang-MP0590-Ab-2 | Anti-Canine HLA-G monoclonal antibody | Canine |
GM-Tg-bovg-MP0590-Ab-1/ GM-Tg-bovg-MP0590-Ab-2 | Anti-Bovine HLA-G monoclonal antibody | Bovine |
GM-Tg-equg-MP0590-Ab-1/ GM-Tg-equg-MP0590-Ab-2 | Anti-Equine HLA-G monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0590-Ab-1/ GM-Tg-hg-MP0590-Ab-2; GM-Tg-rg-MP0590-Ab-1/ GM-Tg-rg-MP0590-Ab-2; GM-Tg-mg-MP0590-Ab-1/ GM-Tg-mg-MP0590-Ab-2; GM-Tg-cynog-MP0590-Ab-1/ GM-Tg-cynog-MP0590-Ab-2; GM-Tg-felg-MP0590-Ab-1/ GM-Tg-felg-MP0590-Ab-2; GM-Tg-cang-MP0590-Ab-1/ GM-Tg-cang-MP0590-Ab-2; GM-Tg-bovg-MP0590-Ab-1/ GM-Tg-bovg-MP0590-Ab-2; GM-Tg-equg-MP0590-Ab-1/ GM-Tg-equg-MP0590-Ab-2 |
Products Name | Anti-HLA-G monoclonal antibody |
Format | mab |
Target Name | HLA-G |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-HLA-G benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species HLAG/ HLA-G/ MHC-G VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLV000304 | human HLA-G Lentivirus plasmid |
ORF Viral Vector | vGMLV000304 | human HLA-G Lentivirus particle |
Target information
Target ID | GM-MP0590 |
Target Name | HLA-G |
Gene ID | 3135 |
Gene Symbol and Synonyms | HLA-G,MHC-G |
Uniprot Accession | P17693 |
Uniprot Entry Name | HLAG_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Prostate Cancer |
Gene Ensembl | ENSG00000204632 |
Target Classification | N/A |
The target: HLA-G, gene name: HLA-G, also named as MHC-G. HLA-G belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-G is expressed on fetal derived placental cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exon 6 encodes the cytoplasmic tail. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.